According to the latest news, Chengdu HitGen Drug Development Co., Ltd. will start purchasing new shares on April 1. The stock is referred to as HitGen, the purchase code is 78722, and the stock code is 68822. Top purchases require a market price of 6.5 100,000 yuan. The editor of Jintou below will introduce to you when will the Chengdu leader be listed?
The company was founded in 2012. Since its establishment, it has been centered on the research and creation of DNA code compound library technology, focusing on the early link development of original new drugs - the discovery of hit compounds and lead compounds. It is one of the very few in China. Few companies master DEL's core technology. The company has 900 compound libraries and about 400 billion compound structures. It is one of the world's largest DNA code small molecule entity compound libraries.
Chengdu leader in 2017 and 2018 , the operating income achieved in 2019 was 53 million yuan, 151 million yuan, and 264 million yuan respectively. The average annual compound growth rate of the company's operating income from 2017 to 2019 reached 122% and 81%, showing a good growth trend overall. As of the end of the reporting period, Chengdu Leaders have obtained 24 invention patent licenses, and more than 80 domestic and foreign patents are being applied for.
Chengdu Leaders’ online release date is April 1, 2020 (9:15-11:30, 13 :00-15:00), the winning number announcement and winning number payment date are April 3, 2020. Then, according to the editor, the probability of Chengdu leaders being officially listed in mid-April, and the winning income is not yet known.< /p>